1.
|
Phase: Phase IV Type: Supportive care, Treatment Status: Completed Age: Postmenopausal Sponsor: Pharmaceutical / Industry Protocol IDs: D5392C00050, SABRE, NCT00082277
|
|
2.
|
Phase: Phase IV Type: Biomarker/Laboratory analysis, Supportive care Status: Closed Age: 65 and over Sponsor: Other Protocol IDs: PRO06080002 (REBBeCA II), NCT00485953
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N01C8, NCI-P02-0229, N01C8, NCT00043069
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N02C1, N02C1, NCT00054418
|
|
5.
|
Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SA-CMX-01, NCT00426777
|
|
6.
|
Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID03-0124, NCT00452439
|
|
7.
|
Phase: Phase III Type: Natural history/Epidemiology, Supportive care Status: Completed Age: 45 and over Sponsor: NCI, Other Protocol IDs: MA27B, CAN-NCIC-MA27B, SWOG-NCIC-MA27B, NCCTG-NCIC-MA27B, CAN-NCIC-BONE, CDR0000483099, NCIC-MA.27B, NCT00354302
|
|
8.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: SUNY UMU IRB # 4689, NCT00145704
|
|
9.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology Status: Closed Age: Not specified Sponsor: Other Protocol IDs: PROVISTII, NCT01144481
|